Sapre, M., Tremblay, D., Leiter, A., Coltoff, A., Geevarghese, A., Mascarhenas, J., & Gallagher, E. (2019). SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms. J Endocr Soc.

Sapre, Manali, Douglas Tremblay, Amanda Leiter, Alexander Coltoff, Anita Geevarghese, John Mascarhenas, et Emily Gallagher. "SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients With Myeloproliferative Neoplasms." J Endocr Soc 2019.

Sapre, Manali, et al. "SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients With Myeloproliferative Neoplasms." J Endocr Soc 2019.